Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on July 8, 2025
US Navy Veterans Lung Cancer Advocate Begins a National Compensation Initiative for Navy Veterans or Individuals Who Now Have Lung Cancer Because of Workplace Exposure to Asbestos Prior to 1983
EIN Presswire
·
July 8, 2025
WASHINGTON, DC, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- The US Navy Veterans Lung Cancer Advocate says, "We are passionate advocates for navy veterans or individuals who had significant workplace exposure to asbestos prior to 1983 and who have …
Vascular Access Device Market Projected to Reach USD 8.18 Billion by 2032, Growing at a CAGR of 6.64% To 2025-2032
EIN Presswire
·
July 8, 2025
Vascular Access Device Industry revenue is expected to grow by 6.64% from 2024 to 2032, reaching nearly USD 8.18 Billion in 2032 ATLANTA, GA, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the …
AI in Healthcare: Taction Software Empowers Start-ups and Founders With Smarter, Faster Innovations
EIN Presswire
·
July 8, 2025
Taction Software harnesses AI and automation to help healthcare startups, doctors, and hospitals streamline operations and drive innovation. AUSTIN, TX, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- Taction Software, a leading custom software …
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
GlobeNewswire
·
July 8, 2025
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for infectious diseases …
Pharmaceutical Logistics Market Grows at 5.1% Compound annual growth rate (CAGR) to Reach US$106.8 Billion by 2031
EIN Presswire
·
July 8, 2025
Growth in pharmaceutical sector and rise in demand for reverse logistics have boosted the growth of the global pharmaceutical logistics market. WILMINGTON, NEW CASTLE, DE, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- As per the report published by …
Medical Supplierz Welcomes International Medical Equipment Buyers
EIN Presswire
·
July 8, 2025
KUWAIT, KUWAIT, July 8, 2025 /EINPresswire.com/ -- Medical Supplierz, a specialized B2B digital marketplace for healthcare procurement, has opened its platform to verified international medical equipment buyers as part of its ongoing effort to improve …
Dr. Speron’s Natural Skin Care Emphasizes Ingredient Transparency in Clean Beauty Movement
EIN Presswire
·
July 8, 2025
Dr. Speron’s Natural Skin Care Emphasizes Ingredient Transparency in Clean Beauty Movement CHICAGO, IL, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- As the clean beauty movement continues to gain momentum, consumers are increasingly seeking …
AJA Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
July 8, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts
GlobeNewswire
·
July 8, 2025
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) to the Administration for …
دعم وتمكين لمرضى الإكزيما في المنطقة جمجوم فارما والجمعية الإماراتية يطلقان مبادرة "ECZPLORE":
EIN Presswire
·
July 8, 2025
ABU DHABI, UNITED ARAB EMIRATES, July 8, 2025 /EINPresswire.com/ -- تعتبر الإكزيما من الحالات التي يُستهان بها كثيرًا بوصفها "مجرد مشكلة جلدية"، لكنها في الواقع تؤثر على ما هو أبعد من البشرة. بالنسبة لآلاف الأطفال في دولة الإمارات، ولأسرهم التي ترعاهم ، …
Vireo Growth Inc. Completes Loan Refinancing and Upsize With a Bank Led Syndicate Arranged by CEO, John Mazarakis
GlobeNewswire
·
July 8, 2025
-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% -- -- Company also complies expansion of its consolidated credit facilities with an …
More Than Skin Deep: A New Partnership to Ease the Hidden Burden of Eczema in the UAE
EIN Presswire
·
July 8, 2025
ABU DHABI, UNITED ARAB EMIRATES, July 8, 2025 /EINPresswire.com/ -- Eczema, often dismissed as “just a skin problem,” affects far more than the skin. For thousands of children in the UAE - and the families who care for them - it’s a relentless battle of …
Creative Biolabs Identifies Lactobacillus gasseri as a Promising Next-Generation Probiotic
EIN Presswire
·
July 8, 2025
Creative Biolabs has long focused on Lactobacillus gasseri and its potential as a next-generation probiotic for precision microbiota-based therapies. SHIRLEY, NY, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- As part of their research, scientists at …
Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock
GlobeNewswire
·
July 8, 2025
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an …
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model
GlobeNewswire
·
July 8, 2025
TORONTO and HAIFA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical results demonstrating that 100% of small animals treated with a …
Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
GlobeNewswire
·
July 8, 2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 8 juillet 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant engager …
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
GlobeNewswire
·
July 8, 2025
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to …
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
GlobeNewswire
·
July 8, 2025
Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second quarter 2025 …
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
GlobeNewswire
·
July 8, 2025
- SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA - - Solid expects to initiate Phase …